Antibody data
- Antibody Data
- Antigen structure
- References [53]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [1]
- Flow cytometry [6]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB100-664 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB100-664, RRID:AB_10001947
- Product name
- Mouse Monoclonal VEGF Antibody
- Antibody type
- Monoclonal
- Description
- Protein G purified. This VEGF Antibody (VG1) detects the 189, 165 and 121 isoforms of VEGF
- Reactivity
- Human, Mouse, Rat, Canine
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.1 mg
- Concentration
- 1 mg/ml
- Storage
- Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Submitted references Supercritical Carbon Dioxide-decellularized Porcine Acellular Dermal Matrix combined with Autologous Adipose-derived Stem Cells: Its Role in Accelerated Diabetic Wound Healing.
Cardio-renal Exosomes in Myocardial Infarction Serum Regulate Proangiogenic Paracrine Signaling in Adipose Mesenchymal Stem Cells.
Functionalized Polycaprolactone/Hydroxyapatite Composite Microspheres for Promoting Bone Consolidation in a Rat Distraction Osteogenesis Model.
Mechanism of the hypoxia inducible factor 1/hypoxic response element pathway in rat myocardial ischemia/diazoxide post‑conditioning.
Effects of antibodies against human parvovirus B19 on angiogenic signaling.
Genome-wide translational reprogramming of genes important for myocyte functions in overload-induced heart failure.
Maternal Vitamin D Deficiency Causes Sustained Impairment of Lung Structure and Function and Increases Susceptibility to Hyperoxia-induced Lung Injury in Infant Rats.
Immunomodulation by dimethyl fumarate treatment improves mouse sciatic nerve regeneration.
An immunofluorescence study on VEGF and extracellular matrix proteins in human periodontal ligament during tooth movement.
Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
Immunohistochemical Biomarkers of Survival in Patients With Adenocarcinoma of the Uterine Cervix Receiving Chemoradiotherapy.
Salinomycin inhibits breast cancer progression via targeting HIF-1α/VEGF mediated tumor angiogenesis in vitro and in vivo.
Vascularized 3D printed scaffolds for promoting bone regeneration.
Aerosolized deferoxamine administration in mouse model of bronchopulmonary dysplasia improve pulmonary development.
Highly efficient local delivery of endothelial progenitor cells significantly potentiates angiogenesis and full-thickness wound healing.
Enhancement of bone regeneration with the accordion technique via HIF-1α/VEGF activation in a rat distraction osteogenesis model.
Aptamer Internalization via Endocytosis Inducing S-Phase Arrest and Priming Maver-1 Lymphoma Cells for Cytarabine Chemotherapy.
Physical disruption of cell-cell contact induces VEGF expression in RPE cells.
Immunohistochemical studies and fluorodeoxyglucose uptake on positron emission tomography in pharyngeal cancer for predicting radiotherapy-based treatment outcomes.
Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis.
Bilirubin modulated cytokines, growth factors and angiogenesis to improve cutaneous wound healing process in diabetic rats.
Immunohistochemical overexpression of hypoxia-induced factor 1α associated with slow reduction in 18fluoro-2-deoxy-D-glucose uptake for chemoradiotherapy in patients with pharyngeal cancer.
Hyperbranched polyglycerol is superior to glucose for long-term preservation of peritoneal membrane in a rat model of chronic peritoneal dialysis.
Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound.
Novel Etoposide Analogue Modulates Expression of Angiogenesis Associated microRNAs and Regulates Cell Proliferation by Targeting STAT3 in Breast Cancer.
HIF-1α disturbs osteoblasts and osteoclasts coupling in bone remodeling by up-regulating OPG expression.
Hypoxia-Inducible Factor-1α Is Associated With Sprouting Angiogenesis in the Murine Laser-Induced Choroidal Neovascularization Model.
Deferoxamine modulates cytokines and growth factors to accelerate cutaneous wound healing in diabetic rats.
Drug-induced hypothermia as beneficial treatment before and after cerebral ischemia.
A Chinese 2-herb formula (NF3) promotes hindlimb ischemia-induced neovascularization and wound healing of diabetic rats.
Atorvastatin for ovarian torsion: effects on follicle counts, AMH, and VEGF expression.
Peroxisome proliferator-activated receptor δ agonist, HPP593, prevents renal necrosis under chronic ischemia.
β-Cell regeneration mediated by human bone marrow mesenchymal stem cells.
A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer.
Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo.
Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells.
Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression.
Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.
Vascular endothelial growth factor in inflammatory bowel disease.
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer.
Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas.
Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas.
Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer.
Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways.
Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo.
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression.
Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1.
Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Chou PR, Lin YN, Wu SH, Lin SD, Srinivasan P, Hsieh DJ, Huang SH
International journal of medical sciences 2020;17(3):354-367
International journal of medical sciences 2020;17(3):354-367
Cardio-renal Exosomes in Myocardial Infarction Serum Regulate Proangiogenic Paracrine Signaling in Adipose Mesenchymal Stem Cells.
Gao L, Mei S, Zhang S, Qin Q, Li H, Liao Y, Fan H, Liu Z, Zhu H
Theranostics 2020;10(3):1060-1073
Theranostics 2020;10(3):1060-1073
Functionalized Polycaprolactone/Hydroxyapatite Composite Microspheres for Promoting Bone Consolidation in a Rat Distraction Osteogenesis Model.
Wen G, Xu J, Wu T, Zhang S, Chai Y, Kang Q, Li G
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2020 May;38(5):961-971
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2020 May;38(5):961-971
Mechanism of the hypoxia inducible factor 1/hypoxic response element pathway in rat myocardial ischemia/diazoxide post‑conditioning.
Li J, Zhou W, Chen W, Wang H, Zhang Y, Yu T
Molecular medicine reports 2020 Mar;21(3):1527-1536
Molecular medicine reports 2020 Mar;21(3):1527-1536
Effects of antibodies against human parvovirus B19 on angiogenic signaling.
Su CC, Hsu TC, Hsiao CH, Chiu CC, Tzang BS
Molecular medicine reports 2020 Mar;21(3):1320-1327
Molecular medicine reports 2020 Mar;21(3):1320-1327
Genome-wide translational reprogramming of genes important for myocyte functions in overload-induced heart failure.
Guo Q, Zhang Y, Zhang S, Jin J, Pang S, Wu X, Zhang W, Bi X, Zhang Y, Zhang Q, Jiang F
Biochimica et biophysica acta. Molecular basis of disease 2020 Mar 1;1866(3):165649
Biochimica et biophysica acta. Molecular basis of disease 2020 Mar 1;1866(3):165649
Maternal Vitamin D Deficiency Causes Sustained Impairment of Lung Structure and Function and Increases Susceptibility to Hyperoxia-induced Lung Injury in Infant Rats.
Mandell EW, Ryan S, Seedorf GJ, Gonzalez T, Smith BJ, Fleet JC, Abman SH
American journal of respiratory cell and molecular biology 2020 Jul;63(1):79-91
American journal of respiratory cell and molecular biology 2020 Jul;63(1):79-91
Immunomodulation by dimethyl fumarate treatment improves mouse sciatic nerve regeneration.
Bombeiro AL, Pereira BTN, Bonfanti AP, Oliveira ALR
Brain research bulletin 2020 Jul;160:24-32
Brain research bulletin 2020 Jul;160:24-32
An immunofluorescence study on VEGF and extracellular matrix proteins in human periodontal ligament during tooth movement.
Militi A, Cutroneo G, Favaloro A, Matarese G, Di Mauro D, Lauritano F, Centofanti A, Cervino G, Nicita F, Bramanti A, Rizzo G
Heliyon 2019 Oct;5(10):e02572
Heliyon 2019 Oct;5(10):e02572
Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
Saito H, Tanaka K, Fujiwara M, Iwasaki T, Numata T, Oda A, Kanno M, Tanaka M, Eiro M, Satoh M, Kazama JJ
CEN case reports 2019 Nov;8(4):239-245
CEN case reports 2019 Nov;8(4):239-245
Immunohistochemical Biomarkers of Survival in Patients With Adenocarcinoma of the Uterine Cervix Receiving Chemoradiotherapy.
Lin YC, Chen RY, Liang JA, Hung YC, Yeh LS, Chang WC, Lin WC, Chang YY, Chen SW
Anticancer research 2019 Jun;39(6):3231-3240
Anticancer research 2019 Jun;39(6):3231-3240
Salinomycin inhibits breast cancer progression via targeting HIF-1α/VEGF mediated tumor angiogenesis in vitro and in vivo.
Dewangan J, Srivastava S, Mishra S, Divakar A, Kumar S, Rath SK
Biochemical pharmacology 2019 Jun;164:326-335
Biochemical pharmacology 2019 Jun;164:326-335
Vascularized 3D printed scaffolds for promoting bone regeneration.
Yan Y, Chen H, Zhang H, Guo C, Yang K, Chen K, Cheng R, Qian N, Sandler N, Zhang YS, Shen H, Qi J, Cui W, Deng L
Biomaterials 2019 Jan;190-191:97-110
Biomaterials 2019 Jan;190-191:97-110
Aerosolized deferoxamine administration in mouse model of bronchopulmonary dysplasia improve pulmonary development.
Chen Y, Gao S, Yan Y, Qian J, Chen H
American journal of translational research 2018;10(1):325-332
American journal of translational research 2018;10(1):325-332
Highly efficient local delivery of endothelial progenitor cells significantly potentiates angiogenesis and full-thickness wound healing.
Wang C, Wang Q, Gao W, Zhang Z, Lou Y, Jin H, Chen X, Lei B, Xu H, Mao C
Acta biomaterialia 2018 Mar 15;69:156-169
Acta biomaterialia 2018 Mar 15;69:156-169
Enhancement of bone regeneration with the accordion technique via HIF-1α/VEGF activation in a rat distraction osteogenesis model.
Xu J, Sun Y, Wu T, Liu Y, Shi L, Zhang J, Kang Q, Chai Y, Li G
Journal of tissue engineering and regenerative medicine 2018 Feb;12(2):e1268-e1276
Journal of tissue engineering and regenerative medicine 2018 Feb;12(2):e1268-e1276
Aptamer Internalization via Endocytosis Inducing S-Phase Arrest and Priming Maver-1 Lymphoma Cells for Cytarabine Chemotherapy.
Li H, Yang S, Yu G, Shen L, Fan J, Xu L, Zhang H, Zhao N, Zeng Z, Hu T, Wen J, Zu Y
Theranostics 2017;7(5):1204-1213
Theranostics 2017;7(5):1204-1213
Physical disruption of cell-cell contact induces VEGF expression in RPE cells.
Farjood F, Vargis E
Molecular vision 2017;23:431-446
Molecular vision 2017;23:431-446
Immunohistochemical studies and fluorodeoxyglucose uptake on positron emission tomography in pharyngeal cancer for predicting radiotherapy-based treatment outcomes.
Lin YC, Chen RY, Chen SW, Hsieh TC, Yen KY, Liang JA, Yang SN, Wang YC, Chen YH, Chow NH, Kao CH
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 2017 Jun;42(3):608-619
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 2017 Jun;42(3):608-619
Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis.
Su JC, Mar AC, Wu SH, Tai WT, Chu PY, Wu CY, Tseng LM, Lee TC, Chen KF, Liu CY, Chiu HC, Shiau CW
Scientific reports 2016 Jul 1;6:28888
Scientific reports 2016 Jul 1;6:28888
Bilirubin modulated cytokines, growth factors and angiogenesis to improve cutaneous wound healing process in diabetic rats.
Ram M, Singh V, Kumawat S, Kant V, Tandan SK, Kumar D
International immunopharmacology 2016 Jan;30:137-149
International immunopharmacology 2016 Jan;30:137-149
Immunohistochemical overexpression of hypoxia-induced factor 1α associated with slow reduction in 18fluoro-2-deoxy-D-glucose uptake for chemoradiotherapy in patients with pharyngeal cancer.
Chen SW, Lin YC, Chen RY, Hsieh TC, Yen KY, Liang JA, Yang SN, Wang YC, Chen YH, Chow NH, Kao CH
European journal of nuclear medicine and molecular imaging 2016 Dec;43(13):2343-2352
European journal of nuclear medicine and molecular imaging 2016 Dec;43(13):2343-2352
Hyperbranched polyglycerol is superior to glucose for long-term preservation of peritoneal membrane in a rat model of chronic peritoneal dialysis.
Du C, Mendelson AA, Guan Q, Dairi G, Chafeeva I, da Roza G, Kizhakkedathu JN
Journal of translational medicine 2016 Dec 13;14(1):338
Journal of translational medicine 2016 Dec 13;14(1):338
Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound.
Chen H, Jia P, Kang H, Zhang H, Liu Y, Yang P, Yan Y, Zuo G, Guo L, Jiang M, Qi J, Liu Y, Cui W, Santos HA, Deng L
Advanced healthcare materials 2016 Apr 20;5(8):907-18
Advanced healthcare materials 2016 Apr 20;5(8):907-18
Novel Etoposide Analogue Modulates Expression of Angiogenesis Associated microRNAs and Regulates Cell Proliferation by Targeting STAT3 in Breast Cancer.
Srinivas C, Ramaiah MJ, Lavanya A, Yerramsetty S, Kavi Kishor PB, Basha SA, Kamal A, Bhadra U, Bhadra MP
PloS one 2015;10(11):e0142006
PloS one 2015;10(11):e0142006
HIF-1α disturbs osteoblasts and osteoclasts coupling in bone remodeling by up-regulating OPG expression.
Shao J, Zhang Y, Yang T, Qi J, Zhang L, Deng L
In vitro cellular & developmental biology. Animal 2015 Sep;51(8):808-14
In vitro cellular & developmental biology. Animal 2015 Sep;51(8):808-14
Hypoxia-Inducible Factor-1α Is Associated With Sprouting Angiogenesis in the Murine Laser-Induced Choroidal Neovascularization Model.
André H, Tunik S, Aronsson M, Kvanta A
Investigative ophthalmology & visual science 2015 Oct;56(11):6591-604
Investigative ophthalmology & visual science 2015 Oct;56(11):6591-604
Deferoxamine modulates cytokines and growth factors to accelerate cutaneous wound healing in diabetic rats.
Ram M, Singh V, Kumawat S, Kumar D, Lingaraju MC, Uttam Singh T, Rahal A, Kumar Tandan S, Kumar D
European journal of pharmacology 2015 Oct 5;764:9-21
European journal of pharmacology 2015 Oct 5;764:9-21
Drug-induced hypothermia as beneficial treatment before and after cerebral ischemia.
Johansen FF, Hasseldam H, Rasmussen RS, Bisgaard AS, Bonfils PK, Poulsen SS, Hansen-Schwartz J
Pathobiology : journal of immunopathology, molecular and cellular biology 2014;81(1):42-52
Pathobiology : journal of immunopathology, molecular and cellular biology 2014;81(1):42-52
A Chinese 2-herb formula (NF3) promotes hindlimb ischemia-induced neovascularization and wound healing of diabetic rats.
Tam JC, Ko CH, Lau KM, To MH, Kwok HF, Chan YW, Siu WS, Etienne-Selloum N, Lau CP, Chan WY, Leung PC, Fung KP, Schini-Kerth VB, Lau CB
Journal of diabetes and its complications 2014 Jul-Aug;28(4):436-47
Journal of diabetes and its complications 2014 Jul-Aug;28(4):436-47
Atorvastatin for ovarian torsion: effects on follicle counts, AMH, and VEGF expression.
Parlakgumus HA, Aka Bolat F, Bulgan Kilicdag E, Simsek E, Parlakgumus A
European journal of obstetrics, gynecology, and reproductive biology 2014 Apr;175:186-90
European journal of obstetrics, gynecology, and reproductive biology 2014 Apr;175:186-90
Peroxisome proliferator-activated receptor δ agonist, HPP593, prevents renal necrosis under chronic ischemia.
Fedorova LV, Sodhi K, Gatto-Weis C, Puri N, Hinds TD Jr, Shapiro JI, Malhotra D
PloS one 2013;8(5):e64436
PloS one 2013;8(5):e64436
β-Cell regeneration mediated by human bone marrow mesenchymal stem cells.
Milanesi A, Lee JW, Li Z, Da Sacco S, Villani V, Cervantes V, Perin L, Yu JS
PloS one 2012;7(8):e42177
PloS one 2012;7(8):e42177
A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer.
Hong DS, Kurzrock R, Oh Y, Wheler J, Naing A, Brail L, Callies S, André V, Kadam SK, Nasir A, Holzer TR, Meric-Bernstam F, Fishman M, Simon G
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Oct 15;17(20):6582-91
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Oct 15;17(20):6582-91
Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo.
Kunze D, Wuttig D, Kausch I, Blietz C, Blumhoff L, Burmeister Y, Kraemer K, Fuessel S, Toma M, Schwenzer B, Meye A, Grimm MO, Hakenberg OW, Jocham D, Wirth MP
International journal of oncology 2008 May;32(5):1049-56
International journal of oncology 2008 May;32(5):1049-56
Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells.
Ptaszynska MM, Pendrak ML, Bandle RW, Stracke ML, Roberts DD
Molecular cancer research : MCR 2008 Mar;6(3):352-63
Molecular cancer research : MCR 2008 Mar;6(3):352-63
Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression.
Couvelard A, O'Toole D, Turley H, Leek R, Sauvanet A, Degott C, Ruszniewski P, Belghiti J, Harris AL, Gatter K, Pezzella F
British journal of cancer 2005 Jan 17;92(1):94-101
British journal of cancer 2005 Jan 17;92(1):94-101
Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.
Van der Auwera I, Van Laere SJ, Van den Eynden GG, Benoy I, van Dam P, Colpaert CG, Fox SB, Turley H, Harris AL, Van Marck EA, Vermeulen PB, Dirix LY
Clinical cancer research : an official journal of the American Association for Cancer Research 2004 Dec 1;10(23):7965-71
Clinical cancer research : an official journal of the American Association for Cancer Research 2004 Dec 1;10(23):7965-71
Vascular endothelial growth factor in inflammatory bowel disease.
Kapsoritakis A, Sfiridaki A, Maltezos E, Simopoulos K, Giatromanolaki A, Sivridis E, Koukourakis MI
International journal of colorectal disease 2003 Sep;18(5):418-22
International journal of colorectal disease 2003 Sep;18(5):418-22
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
Giatromanolaki A, Sivridis E, Maltezos E, Papazoglou D, Simopoulos C, Gatter KC, Harris AL, Koukourakis MI
Journal of clinical pathology 2003 Mar;56(3):209-13
Journal of clinical pathology 2003 Mar;56(3):209-13
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
Giatromanolaki A, Sivridis E, Maltezos E, Papazoglou D, Simopoulos C, Gatter KC, Harris AL, Koukourakis MI
Journal of clinical pathology 2003 Mar;56(3):209-13
Journal of clinical pathology 2003 Mar;56(3):209-13
DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer.
Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Wykoff CC, Gatter KC, Harris AL
The Journal of pathology 2003 Jun;200(2):222-8
The Journal of pathology 2003 Jun;200(2):222-8
Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas.
Giatromanolaki A, Koukourakis MI, Simopoulos C, Polychronidis A, Sivridis E
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2003 Dec;29(10):879-83
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2003 Dec;29(10):879-83
Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas.
Giatromanolaki A, Koukourakis MI, Simopoulos C, Polychronidis A, Sivridis E
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2003 Dec;29(10):879-83
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2003 Dec;29(10):879-83
Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer.
Salgado R, Benoy I, Weytjens R, Van Bockstaele D, Van Marck E, Huget P, Hoylaerts M, Vermeulen P, Dirix LY
British journal of cancer 2002 Dec 2;87(12):1437-44
British journal of cancer 2002 Dec 2;87(12):1437-44
Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways.
Giatromanolaki A, Koukourakis MI, Sivridis E, O'Byrne K, Cox G, Thorpe PE, Gatter KC, Harris AL
Clinical cancer research : an official journal of the American Association for Cancer Research 2000 May;6(5):1917-21
Clinical cancer research : an official journal of the American Association for Cancer Research 2000 May;6(5):1917-21
Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
Koukourakis MI, Giatromanolaki A, Thorpe PE, Brekken RA, Sivridis E, Kakolyris S, Georgoulias V, Gatter KC, Harris AL
Cancer research 2000 Jun 1;60(11):3088-95
Cancer research 2000 Jun 1;60(11):3088-95
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
Adams J, Carder PJ, Downey S, Forbes MA, MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Walker JJ, Cairnduff F, Selby PJ, Perren TJ, Lansdown M, Banks RE
Cancer research 2000 Jun 1;60(11):2898-905
Cancer research 2000 Jun 1;60(11):2898-905
The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo.
Zhang HT, Scott PA, Morbidelli L, Peak S, Moore J, Turley H, Harris AL, Ziche M, Bicknell R
British journal of cancer 2000 Jul;83(1):63-8
British journal of cancer 2000 Jul;83(1):63-8
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ, Koukourakis MI, Giatromanolaki A, Cox G, Turley H, Steward WP, Gatter K, Harris AL
British journal of cancer 2000 Apr;82(8):1427-32
British journal of cancer 2000 Apr;82(8):1427-32
Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression.
Kakolyris S, Giatromanolaki A, Koukourakis M, Leigh IM, Georgoulias V, Kanavaros P, Sivridis E, Gatter KC, Harris AL
Cancer research 1999 Nov 1;59(21):5602-7
Cancer research 1999 Nov 1;59(21):5602-7
Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1.
Turley H, Scott PA, Watts VM, Bicknell R, Harris AL, Gatter KC
The Journal of pathology 1998 Nov;186(3):313-8
The Journal of pathology 1998 Nov;186(3):313-8
Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Giatromanolaki A, Koukourakis MI, Kakolyris S, Turley H, O'Byrne K, Scott PA, Pezzella F, Georgoulias V, Harris AL, Gatter KC
Clinical cancer research : an official journal of the American Association for Cancer Research 1998 Dec;4(12):3017-24
Clinical cancer research : an official journal of the American Association for Cancer Research 1998 Dec;4(12):3017-24
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: VEGF Antibody (VG1) [NB100-664] - HUVEC and 293T cells transfected with a plasmid expressing human VEGF165 at 1:1000. Image provided by verified customer review.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: VEGF Antibody (VG1) [NB100-664] - Analysis of VEGF in human kidney protein using NB100-664.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: VEGF Antibody (VG1) [NB100-664] - FFPE human angiosarcoma tissue section using VEGF antibody (clone VG1). The endothelial cells of the blood vessels and most of the cancer cells showed strong positivity for VEGF protein.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow Cytometry: VEGF Antibody (VG1) [NB100-664] - Analysis of PerCP conjugate of NB100-664. An intracellular stain was performed on HUVEC cells with VEGF (VG1) antibody NB100-664PCP (blue) and a matched isotype control NBP2-27287PCP (orange). Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 10 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to PerCP.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow Cytometry: VEGF Antibody (VG1) [NB100-664] - An intracellular stain was performed on U-937 cells with NB100-664F (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 10 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to FITC.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow Cytometry: VEGF Antibody (VG1) [NB100-664] - An intracellular stain was performed on U-937 cells with VEGF Antibody (VG1) NB100-664 and a matched isotype control. Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 1 ug/mL for 30 minutes at room temperature, followed by Mouse F(ab)2 IgG (H+L) PE-conjugated Antibody (R&D Systems, F0102B).
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow Cytometry: VEGF Antibody (VG1) [NB100-664] - An intracellular stain was performed on U937 cells with VEGF [VG1] Antibody NB100-664APC (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 2.5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Allophycocyanin.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow Cytometry: VEGF Antibody (VG1) [NB100-664] - An intracellular stain was performed on U-87 cells with VEGF [VG1] Antibody NB100-664APC (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 2.5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Allophycocyanin.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow Cytometry: VEGF Antibody (VG1) [NB100-664] - An intracellular stain was performed on U-87 cells with VEGF [VG1] Antibody NB100-664AF488 (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Alexa Fluor 488.